PHILADELPHIA – At the American Association for Clinical Chemistry annual meeting here today, Theranos CEO Elizabeth Holmes offered a first look at the components of the company's miniLab technology with which it hopes to make diagnostic testing broadly accessible in a decentralized manner.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.